Amerijet awarded CEIV Pharma certification
11 / 07 / 2017
Amerijet has become the first US-based all-cargo airline to be awarded IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV) Pharma certification.
Vic Karjian, president and chief executive of Amerijet International Airlines, said: “This certification reconfirms our commitment to offering the highest consistent quality, professionalism and transparency to our customers.
"Being the first all-cargo airline from the US to receive the CEIV in pharmaceutical logistics is a direct result of hard work and the investments we have made over the last few years to our temperature controlled (ATC) program.”
Amerijet operates its own dedicated freighter fleet of Boeing 767-300/200 aircraft from its primary hub at the Miami International Airport to 38 destinations throughout the Caribbean, Mexico, Central and South America.
The airline transports over 136,000 tonnes of freight annually, including 30,000 tonnes of temperature controlled products.
Amerijet’s temperature controlled handling facility at Miami airport includes a custom-built cooling facility equipped with active alarm systems, temperature data recorders and 24/7 CCTV monitoring.
Computer monitored pharmaceutical cooling chambers provide storage environments for ambient 15°C – 25°C, chilled at 2°C – 8°C, and frozen at -0°C shipments.
The carrier is to launch a twice a week direct Boeing 767 freighter service to Brussels, a key European pharma hub, in the second quarter of 2018.
Rasheme Richardson, vice president of airport operations for Amerijet added: “As an airline, our role in the supply chain is to provide safe handling and to ensure temperature integrity for all pharmaceutical shipments.
"We demand the same uniform standards and processes from all of our business partners, including our handlers and trucking companies.
"Complying with the healthcare cold chain logistics standards, expected from pharmaceutical manufacturers and life sciences companies, helps to support the global healthcare initiative of putting patient safety first.”
Glyn Hughes, IATA global head of cargo, said: “Amerijet’s strategy to enhance its pharma shipping offering through investing in the latest cold chain technology and joining the IATA CEIV Pharma certification program demonstrates the airline’s commitment to patient safety.
"We congratulate Amerijet for their achievement in meeting shippers’ expectations in terms of standardization and transparency. This will contribute towards developing a stronger, more competitive and enhanced air cargo service for pharmaceuticals in North and Latin America for this vital sector.”
Amerijet’s global network reaches 476 destinations in Europe, Asia, Pacific, South Africa and the Middle East.
Within the US, Canada and Mexico, Amerijet partners with local asset-based carriers to provide full truckload, less-than-truckload and expedited services.